Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shares were up 12.5% on Tuesday. The stock traded as high as C$0.14 and last traded at C$0.14. 175,000 shares changed hands during mid-day trading, an increase of 42% from the average daily volume of 122,825 shares. The stock had previously closed at C$0.12.
Voyageur Pharmaceuticals Stock Up 12.5%
The company has a fifty day simple moving average of C$0.15 and a 200-day simple moving average of C$0.13. The company has a quick ratio of 0.84, a current ratio of 0.23 and a debt-to-equity ratio of 9.80. The firm has a market cap of C$30.56 million, a P/E ratio of -6.75 and a beta of 0.88.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- Coca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest Strength
- Apple’s Foldable iPhone Sold Out in Minutes, But Wall Street Has Questions
- Netflix Is Making Big Changes, But Can It Fix What’s Really Hurting Growth?
- Charging Ahead: Solid Power’s Pilot Line Leaves the Lab
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
